Anti-Inflammatory Medications for Cystic Fibrosis Lung Disease: Selecting the Most Appropriate Agent

Author： Chmiel James F.   Konstan Michael W.  

Publisher： Adis International

ISSN： 1176-3450

Source： Treatments in Respiratory Medicine, Vol.4, Iss.4, 2005-01, pp. : 255-273

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inflammation, Hyperinflammation & Cystic Fibrosis Lung Disease - A Paradigm Shift?

By  

Current Respiratory Medicine Reviews, Vol. 5, Iss. 3, 2009-08 ,pp. : 136-148

Bentham Science Publishers

Access to resources Recommend Favorite

Nonsteroidal Anti-Inflammatory Drugs and the Risk of Parkinson Disease

By  

Neuroepidemiology, Vol. 28, Iss. 4, 2007-09 ,pp. : 193-196

Karger

Access to resources Recommend Favorite

Relapse of Inflammatory Bowel Disease Associated With Use of Nonsteroidal Anti-Inflammatory Drugs

By Meyer Angela   Ramzan Nizar   Heigh Russell   Leighton Jonathan  

Digestive Diseases and Sciences, Vol. 51, Iss. 1, 2006-01 ,pp. : 168-172

Springer Publishing Company

Access to resources Recommend Favorite

An (Anti)-Inflammatory Microbiota: Defining the Role in Inflammatory Bowel Disease?

By  

Digestive Diseases, Vol. 34, Iss. 1-2, 2016-03 ,pp. : 64-71

Karger

Access to resources Recommend Favorite

T-cell co-stimulators as anti-inflammatory targets for atherosclerotic disease

By Wang Xiaosong  

Future Cardiology, Vol. 2, Iss. 2, 2006-03 ,pp. : 187-195

Future Medicine

Access to resources Recommend Favorite